| US 7,547,456 B2 | ||
| Composition containing feverfew extract and use thereof | ||
| Katharine M. Martin, Ringoes, N.J. (US); and Claude Saliou, Bernardsville, N.J. (US) | ||
| Assigned to Johnson & Johnson Consumer Companies, Inc., Skillman, N.J. (US) | ||
| Filed on Mar. 14, 2002, as Appl. No. 10/99,159. | ||
| Claims priority of provisional application 60/276304, filed on Mar. 16, 2001. | ||
| Prior Publication US 2002/0182166 A1, Dec. 05, 2002 | ||
| Int. Cl. A61K 36/28 (2006.01); A61K 8/02 (2006.01); A61K 33/00 (2006.01); A61K 36/00 (2006.01) | ||
| U.S. Cl. 424—764 [424/401; 424/724; 424/725] | 13 Claims |
| 1. A method of enhancing the firmness or elasticity of or retarding the process of wrinkle or fine line formation in skin,
said method comprising the topical administration to skin in need of such treatment a composition comprising:
(a) a safe and effective amount of a feverfew extract; and
(b) a cosmetically-acceptable topical carrier, wherein said composition comprises less than 0.1% by weight of parthenolide.
|